Generated Thu Dec 12 02:05:17 UTC 2024, FHIR version 5.0.0 for hl7.fhir.us.pq-cmc-fda#2.0.0-ballot (canonical = http://hl7.org/fhir/us/pq-cmc-fda (history)). See Full QA Report
Quality Checks | |||||||||||||||||||||||||
Publisher Version: | IG Publisher Version: v1.8.1 | ||||||||||||||||||||||||
Publication Code: | pq-cmc-fda . PackageId = hl7.fhir.us.pq-cmc-fda, Canonical = http://hl7.org/fhir/us/pq-cmc-fda | ||||||||||||||||||||||||
Realm Check for US: | Snomed: The IG doesn't use SNOMED CT | ||||||||||||||||||||||||
Publication Request: |
| ||||||||||||||||||||||||
Supressed Messages: | 97 Suppressed Issues | ||||||||||||||||||||||||
Dependency Checks: |
| ||||||||||||||||||||||||
Dependent IGs: | no references | ||||||||||||||||||||||||
Global Profiles: | (none declared) | ||||||||||||||||||||||||
Terminology Server(s): | http://tx.fhir.org/r5 (details) | ||||||||||||||||||||||||
HTA Analysis: | All OK | ||||||||||||||||||||||||
R5 Dependencies: | (none) | ||||||||||||||||||||||||
Draft Dependencies: |
| ||||||||||||||||||||||||
Modifier Extensions: | |||||||||||||||||||||||||
Previous Version Comparison: | Comparison with version 1.0.0 | ||||||||||||||||||||||||
IPA Comparison: | n/a | ||||||||||||||||||||||||
IPS Comparison: | n/a | ||||||||||||||||||||||||
Validation Flags: | On: autoLoad; Off: hintAboutNonMustSupport, anyExtensionsAllowed, checkAggregation, showReferenceMessages, noExperimentalContent, displayWarnings | ||||||||||||||||||||||||
Summary: | errors = 0, warn = 0, info = 0, broken links = 0 |
Filename | Errors | Warnings | Hints |
Build Errors | 0 | 0 | 0 |
Suppressed Messages (Warnings, hints, broken links)
01 - Dependencies are on US Core. This IG does not comply with US Core. See US Core Ticket FHIR-44842
02 - Organization conflicts with US Core Organization Profile on identifier codes. National Provider Identifier (NPI), Clinical Laboratory Improvement Amendments (CLIA) Number for laboratories, and NAIC Code are not used to identify drug suppliers. See US Core Ticket FHIR-44853
03 - This is a supplement to the NCI Thesaurus (NCIt) which is in THO. CodeSystem supplements in FHIR don't require registration with the HL7 Terminology organization because they only enhance existing CodeSystems rather than defining new ones. They add localized or context-specific information, such as additional properties or designations, without altering the base CodeSystem. This flexibility allows for tailored implementations without the overhead of global registration.
04 - Registered new code system with THO and was provided this url as a temporary identifier. Will replace when permanent identifier is provided.
05 - Using UCUM codes like %{WeightToWeight}, %{WeightToVolume}, and %{VolumeToVolume} for drug product specifications offers key advantages: they ensure consistency, reduce errors, meet regulatory requirements (e.g., eCTD, FHIR), simplify data exchange with machine-readable formats, clearly define concentration types (e.g., w/w, w/v, v/v), and support international collaboration by overcoming language and unit barriers. These codes enhance clarity, compliance, and efficiency in pharmaceutical processes, and are not being used in computations.
06 - These are all inherited from Core Specification.
07 - They are inline examples so that they just show in the bundles. Comes from having to restrict references to be bundled only. The usage is set to inline because the publisher does not support remote reference defined in the bundle.
Errors sorted by type